SLC7A11 and hepatoblastoma: In contrast, in hepatoblastoma cells, IGF2 mRNA-binding protein 1 (IGF2BP1) has been identified as the m6A reader, and it was shown to compete with the BTG2/CCR4-NOT complex to bind PABPC1, thereby inhibiting SLC7A11 mRNA deadenylation and promoting its stability, resulting in increased SLC7A11 expression and the eventual inhibition of ferroptosis24.